MedPath

The effect of fluticasone, budesonide and mometasone on nasal polyposis

Phase 3
Recruiting
Conditions
asal polyps.
Nasal polyp
Registration Number
IRCT20190618043934N7
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
32
Inclusion Criteria

Patients with chronic rhinosinusitis with nasal polyps who have undergone sinus endoscopic surgery.
Patients aged 15 to 70 years
Having conscious satisfaction

Exclusion Criteria

Existence of eye disease
Existence of known immunodeficiency disease
Infectious symptoms include purulent discharge from the back of the throat and nose
Having Allergic rhinitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Runny nose. Timepoint: runny nose before and After treatment. Method of measurement: By asking the patient.;Headache. Timepoint: headache before and After treatment. Method of measurement: By asking the patient.;Nasal congestion before and After treatment. Timepoint: nasal congestion. Method of measurement: By asking the patient.;Sinus pain. Timepoint: sinus pain before and After treatment. Method of measurement: By asking the patient.;Pain around the eyes. Timepoint: pain around the eyes before and After treatment. Method of measurement: By asking the patient.;Pus in the nose. Timepoint: pus in the nose before and After treatment. Method of measurement: By asking the patient.;Cough. Timepoint: cough before and After treatment. Method of measurement: By asking the patient.;Decreased sense of smell Before and After Treatment. Timepoint: Decreased sense of Smell Before and After Treatment. Method of measurement: By Asking The Patient.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath